Inflammatory mediators of endothelial injury in sickle cell disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Hematology/Oncology Clinics of North America

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.hoc.2013.11.006PMID 24589266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

  2013cited by this paper
• Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.

  2013cited by this paper
• Endothelin‐1 receptor antagonists regulate cell surface‐associated protein disulfide isomerase in sickle cell disease

  2013cited by this paper
• Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants

  2013cited by this paper
• Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.

  2013cited by this paper
• Nucleosomes and neutrophil activation in sickle cell disease painful crisis

  2013cited by this paper
• Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma

  2013cited by this paper
• Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice1[S]

  2013cited by this paper
• New insights into the versatile roles of platelet FlnA

  2013cited by this paper
• Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

  2013cited by this paper
• Oxidative stress in sickle cell disease

  2013cited by this paper
• Mast cell activation contributes to sickle cell pathobiology and pain in mice.

  2013cited by this paper
• Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease

  2012cited by this paper
• Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease.

  2012cited by this paper
• Platelet Activation and Inhibition iN Sickle cell disease (PAINS) study

  2012cited by this paper
• Ex Vivo Effect of Varespladib on Secretory Phospholipase A2 Alveolar Activity in Infants with ARDS

  2012cited by this paper
• Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)

  2012cited by this paper
• Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia

  2012cited by this paper
• A potent oral P‐selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease

  2012cited by this paper
• Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells.

  2012cited by this paper
• Elevated plasma levels and platelet‐associated expression of the pro‐thrombotic and pro‐inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease

  2012cited by this paper
• Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease

  2012cited by this paper
• Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

  2011cited by this paper
• Severe sickle cell anemia is associated with increased plasma levels of TNF‐R1 and VCAM‐1

  2011cited by this paper
• Pre‐eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission

  2011cited by this paper
• Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin

  2011cited by this paper
• Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

  2011cited by this paper
• Detrimental effects of adenosine signaling in sickle cell disease

  2011cited by this paper
• Protease-activated receptor 2 signaling in inflammation

  2011cited by this paper
• A pilot study of the short‐term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction

  2011cited by this paper
• CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso‐occlusion during hemolytic transfusion reactions

  2011cited by this paper
• Targeting iNKT cells for the treatment of sickle cell disease.

  2011cited by this paper
• Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status.

  2011cited by this paper
• Leukocytosis is a risk factor for lung function deterioration in children with sickle cell disease.

  2011cited by this paper
• Heme Degradation and Vascular Injury

  2010cited by this paper
• A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis

  2010cited by this paper
• P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease*

  2010cited by this paper
• Neurobiological mechanisms of pain in sickle cell disease.

  2010cited by this paper
• Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

  2010cited by this paper
• Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.

  2010cited by this paper
• Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease.

  2010cited by this paper
• Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients.

  2010cited by this paper
• Effects of GMI-1070, a Pan-Selectin Inhibitor, on Leukocyte Adhesion In Sickle Cell Disease: Results From a Phase 1/2 Study

  2010cited by this paper
• CXCR2 mediates NADPH oxidase–independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation

  2010cited by this paper
• GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice.

  2010cited by this paper
• Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.

  2010cited by this paper
• Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease

  2009cited by this paper
• Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse

  2009cited by this paper
• Correlation Between sPLA2-llA and Phosgene-Induced Rat Acute Lung Injury

  2009cited by this paper
• Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

  2009cited by this paper
• Correlation between sPLA2-IIA and phosgene-induced rat acute lung injury.

  2009cited by this paper
• Leukotriene pathway in sickle cell disease: a potential target for directed therapy

  2009cited by this paper
• Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease.

  2009cited by this paper
• Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy

  2009cited by this paper
• Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease.

  2008cited by this paper
• Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease

  2008cited by this paper
• Sickle cell disease vasculopathy: a state of nitric oxide resistance.

  2008cited by this paper
• Modulation of redox pathways in neutrophils from sickle cell disease patients.

  2008cited by this paper
• Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation

  2008cited by this paper
• Blood antioxidant parameters in sickle cell anemia patients in steady state.

  2008cited by this paper
• Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age

  2008cited by this paper
• NEUTROPHIL-DERIVED CIRCULATING FREE DNA (cf-DNA/NETs): A POTENTIAL PROGNOSTIC MARKER FOR POSTTRAUMATIC DEVELOPMENT OF INFLAMMATORY SECOND HIT AND SEPSIS

  2008cited by this paper
• Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso‐occlusion

  2007cited by this paper
• Novel cell death program leads to neutrophil extracellular traps

  2007cited by this paper
• Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B

  2007cited by this paper
• Novel cell death program leads to neutrophil extracellular traps.

  2007cited by this paper
• SICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES

  2007cited by this paper
• Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

  2007cited by this paper
• Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.

  2007cited by this paper
• Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.

  2007cited by this paper
• A network model to predict the risk of death in sickle cell disease.

  2007cited by this paper
• Role for cAMP‐protein kinase A signalling in augmented neutrophil adhesion and chemotaxis in sickle cell disease

  2007cited by this paper
• Association of polymorphisms of IGF1R and genes in the transforming growth factor- beta /bone morphogenetic protein pathway with bacteremia in sickle cell anemia.

  2006cited by this paper
• Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes.

  2006cited by this paper
• Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants

  2006cited by this paper
• Modifier genes and sickle cell anemia

  2006cited by this paper
• Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia: Potential Role for Platelet-Mediated Inflammation

  2006cited by this paper
• Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia.

  2005cited by this paper
• Histamine increases sickle erythrocyte adherence to endothelium

  2005cited by this paper
• Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.

  2005cited by this paper
• Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome.

  2005cited by this paper
• C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study

  2005cited by this paper
• Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients

  2004cited by this paper
• Cytokine profile of sickle cell disease in Oman

  2004cited by this paper
• Inflammatory potential of neutrophils detected in sickle cell disease

  2004cited by this paper
• The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.

  2004cited by this paper
• Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.

  2004cited by this paper
• Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin.

  2004cited by this paper
• Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes.

  2004cited by this paper
• Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.

  2004cited by this paper
• Special Issue of Microcirculation: Examination of the Vascular Pathobiology of Sickle Cell Anemia

  2004cited by this paper
• Neutrophil Extracellular Traps Kill Bacteria

  2004cited by this paper
• Erythrocyte Sickling During Exercise and Thermal Stress

  2004cited by this paper
• Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.

  2004cited by this paper
• Decreased arginine bioavailability and increased serum arginase activity in asthma.

  2004cited by this paper
• Tissue factor-factor VIIa signaling.

  2004cited by this paper
• Vasoactive factors in sickle cell disease: In vitro evidence for endothelin‐1‐mediated vasoconstriction

  2004cited by this paper
• Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor.

  2003cited by this paper
• Different Faces of the Heme-Heme Oxygenase System in Inflammation

  2003cited by this paper
• Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology.

  2003cited by this paper

• Copper to Zinc Ratio in Pediatric Patients with Sickle Cell Disease (Steady-State and Crises)

  2025cites this paper
• Plasma Levels of MicroRNA Let-7c-5p May Predict Risk of Acute Chest Syndrome in Patients with Sickle Cell Disease

  2025cites this paper
• Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations

  2025cites this paper
• Association of cell adhesion molecules with Vaso-occlusive crisis in sickle cell disease

  2025cites this paper
• Sensory, Inflammatory, and Psychosocial Characteristics of Chronic Pain in Adolescents and Young Adults With Sickle Cell Disease

  2025cites this paper
• Red blood cell alloimmunization immunogenetic risk factor.

  2025cites this paper
• Aetiology of sickle cell ischemic priapism: the pathophysiologic triad of hyperhaemolysis, hyperviscosity and hypercoagulability, and their therapeutic implications

  2024cites this paper
• Factors associated with adverse outcome among children with sickle cell disease admitted to the pediatric intensive care unit: an observational cohort

  2024cites this paper
• Targeting ICAM1 to Ameliorate Vaso‐Occlusion and Inflammation in Sickle Cell Disease

  2024cites this paper
• Exploring the genetic mechanisms: SELP gene's contribution to alleviating vaso-occlusive crisis in sickle cell disease.

  2024cites this paper
• Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease

  2023cites this paper
• Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives

  2023cites this paper
• Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation

  2022cites this paper
• Development of curative therapies for sickle cell disease

  2022cites this paper
• Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients.

  2021cites this paper
• Evaluation of the role of CD47 in sickle cell disease

  2021cites this paper
• Pregnancy associated coagulopathies in selected community hospitals in Southwest Nigeria

  2021cites this paper
• Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort

  2021cites this paper
• Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis

  2020cites this paper
• The multifaceted role of ischemia/reperfusion in sickle cell anemia

  2020cites this paper
• Circulating Extracellular Vesicles and Endothelial Damage in Sickle Cell Disease

  2020cites this paper
• Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells

  2020cites this paper
• Review/overview of pain in sickle cell disease.

  2020cites this paper
• Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity.

  2020cites this paper
• The multifaceted role of ischemia/reperfusion in sickle cell anemia.

  2020cites this paper
• Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease

  2019cites this paper
• Sleep disorders and endothelial dysfunction in children with sickle cell anemia.

  2019cites this paper
• Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation.

  2019cites this paper
• Asthma in children with sickle cell disease.

  2019cites this paper
• Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells

  2019cites this paper
• Angiopoietin-2 as a Marker of Retinopathy in Children and Adolescents With Sickle Cell Disease: Relation to Subclinical Atherosclerosis

  2019cites this paper
• Impaired antioxidant capacity causes a disruption of metabolic homeostasis in sickle erythrocytes.

  2019cites this paper
• Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice

  2019cites this paper
• Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks-American Pain Society-American Academy of Pain Medicine Pain Taxonomy Diagnostic Criteria for Acute Sickle Cell Disease Pain.

  2019cites this paper
• Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review

  2019cites this paper
• Single cell analysis of bone marrow derived CD34+ cells from children with sickle cell disease and thalassemia.

  2019cites this paper
• Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children

  2018cites this paper
• A common molecular signature of patients with sickle cell disease revealed by microarray meta-analysis and a genome-wide association study

  2018cites this paper
• Severe pre-eclampsia among pregnant women with sickle cell disease and HIV.

  2018cites this paper
• Nitric oxide pathology and therapeutics in sickle cell disease

  2018cites this paper
• Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis

  2018cites this paper
• Risk factors for vitamin D deficiency in sickle cell disease

  2018cites this paper
• Moderate exercise training decreases inflammation in transgenic sickle cell mice.

  2017cites this paper
• Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia

  2017cites this paper
• Potential therapeutic action of nitrite in sickle cell disease

  2017cites this paper
• Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings

  2017cites this paper
• Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease

  2016cites this paper
• Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein

  2016cites this paper
• Étude des mécanismes impliqués dans l'inflammation, le stress oxydant et le métabolisme de l'oxyde nitrique chez des souris transgéniques drépanocytaires : approches sportive et pharmacologique

  2016cites this paper
• Cardiovascular Adaptations to Anemia and the Vascular Endothelium in Sickle Cell Disease Pathophysiology

  2016cites this paper
• Title The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia

  2016cites this paper
• Inflammatory targets of therapy in sickle cell disease.

  2016cites this paper
• Plasma levels of TGF-β1 in homeostasis of the inflammation in sickle cell disease.

  2016cites this paper
• Single Nucleotide Polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia

  2016cites this paper
• Clinically‐oriented proteomic investigation of sickle cell disease: Opportunities and challenges

  2016cites this paper
• Red cell DAMPs and inflammation

  2016cites this paper
• Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy.

  2016cites this paper
• The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia

  2015cites this paper
• Coagulation activation in sickle cell trait: an exploratory study

  2015cites this paper